Masimo Corporation
About Masimo Corporation
Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
- Ticker
- MASI
- Trading on
- NASDAQ
- ISIN
- US5747951003
- Industry
- Medical Devices
- Sector
- Healthcare
- CEO
- Catherine M. Szyman
- Headquarters
- 52 Discovery, Irvine, CA, United States, 92618
- Employees
- 2,200
- Website
- masimo.com
Metrics
Analyst Insights & forecasts
Based on information from 9 analysts.
Earnings per share (EPS) forecast
| Q2 • 25 | Q3 • 25 | Q4 • 25 | Q1 • 26 | |
|---|---|---|---|---|
| Actual | $1.33 | $1.32 | $1.31 | $1.09 |
| Expected | $1.22 | $1.20 | $1.47 | $1.21 |
| Surprise | 9.02% | 10.00% | -10.82% | -9.92% |
| Beat | Beat | Missed | Current |
Financial Performance
| Q4 • 25 | Q1 • 26 | QoQ growth | |
|---|---|---|---|
| Revenue | $413M | $404M | -2.16% |
| Net income | $68.3M | $57.1M | -16.40% |
| Profit margin | 16.56% | 14.15% | -14.55% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.
FAQs
01How much is a Masimo Corporation share?
Masimo Corporation shares are currently traded for undefined per share.
02How many shares does Masimo Corporation have?
Masimo Corporation currently has 52.4M shares.
03Does Masimo Corporation pay dividends?
No, Masimo Corporation doesn't pay dividends.
04What is Masimo Corporation 52 week high?
Masimo Corporation 52 week high is $179.99.
05What is Masimo Corporation 52 week low?
Masimo Corporation 52 week low is $4.74.
06What is the 200-day moving average of Masimo Corporation?
Masimo Corporation 200-day moving average is $156.66.
07Who is Masimo Corporation CEO?
The CEO of Masimo Corporation is Catherine M. Szyman.
08How many employees Masimo Corporation has?
Masimo Corporation has 2,200 employees.
09What is the market cap of Masimo Corporation?
The market cap of Masimo Corporation is $9.42B.
10What is the P/E of Masimo Corporation?
The current P/E of Masimo Corporation is 44.43.
11What is the EPS of Masimo Corporation?
The EPS of Masimo Corporation is $4.05.
12What is the PEG Ratio of Masimo Corporation?
The PEG Ratio of Masimo Corporation is 4.83.
13What do analysts say about Masimo Corporation?
According to the analysts Masimo Corporation is considered a buy.
